PF3D7_1013700

PF3D7_1013700 (TRX2) is a thioredoxin-like protein that functions as a bona fide component of the Plasmodium Translocon of Exported Proteins (PTEX), the machinery that exports parasite proteins across the parasitophorous vacuole membrane, where it associates with PTEX150, HSP101, EXP2, and PTEX88 (PMID:23869529). TRX2 is not essential for blood-stage survival: its genetic deletion in P. berghei yields viable but slow-growing parasites with reduced in vitro and in vivo growth and a diminished capacity to cause severe disease in a cerebral malaria model, establishing that it optimizes rather than enables PTEX-mediated export (PMID:23869529). Biochemically, TRX2 is a poor substrate for thioredoxin reductase and can instead be reduced by the glutathione system, demonstrating cross-talk between the parasite's glutathione and thioredoxin antioxidant systems (PMID:28479253). Beyond its membership in PTEX, its antioxidant role in export, and this redox connectivity, no further mechanistic detail for TRX2 has been characterized in the available corpus.

1. 2013 Medium

   Establishing that TRX2 is a genuine PTEX subunit answered where this thioredoxin-like protein acts, placing it at the protein-export translocon rather than as a free-standing redox enzyme.

   Evidence Genetic tagging and reciprocal co-immunoprecipitation with PTEX150, HSP101, EXP2, and PTEX88

   PMID:23869529

   Open questions at the time

   • Does not define TRX2's structural position within PTEX or its stoichiometry
   • Does not establish whether TRX2's redox activity is required for its association with the complex
2. 2013 Medium

   Deleting TRX2 tested whether the subunit is essential and showed it is dispensable but growth-optimizing, distinguishing it from core translocon components.

   Evidence Gene knockout in P. berghei with in vitro/in vivo growth assays and a cerebral malaria disease model

   PMID:23869529

   Open questions at the time

   • The molecular basis linking TRX2 loss to reduced growth (e.g. impaired export of specific substrates) is not defined
   • Knockout was done in P. berghei; the phenotype in P. falciparum is not directly tested
3. 2013 Low

   Expression profiling addressed whether TRX2 acts only in blood stages, showing PTEX components including TRX2 are present in gametocytes, mosquito, and liver stages.

   Evidence Stage-specific protein detection across the life cycle

   PMID:23869529

   Open questions at the time

   • Single detection method per stage with no loss-of-function to establish function in these stages
   • Does not show TRX2 is functionally required for export outside asexual blood stages
4. 2017 Medium

   Determining how TRX2 stays reduced addressed a redox-source problem, showing the glutathione system can reduce it since it is a poor thioredoxin-reductase substrate with limited reductase access.

   Evidence In vitro biochemical assay measuring glutathione-mediated reduction of thioredoxins in P. falciparum

   PMID:28479253

   Open questions at the time

   • In vitro assay only; glutathione-dependent reduction of TRX2 within the intact translocon in vivo is not shown
   • Does not connect TRX2's redox state to a specific export or growth outcome

• The specific molecular function of TRX2 within PTEX — the substrates it reduces, whether it unfolds or maintains cargo in an export-competent state, and how its redox activity translates into the growth-optimizing effect — remains unresolved.
• No identified redox substrate of TRX2 within the export pathway
• No structural model of TRX2 in the PTEX complex
• Mechanistic link between TRX2 redox state and PTEX export efficiency undefined